Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease.

Item

http://www.wikidata.org/entity/Q43803084

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Physician-prompting statin the ...... s with coronary heart disease.

@en

Physician-prompting statin the ...... s with coronary heart disease.

@nl

type

Item

label

Physician-prompting statin the ...... s with coronary heart disease.

@en

Physician-prompting statin the ...... s with coronary heart disease.

@nl

prefLabel

Physician-prompting statin the ...... s with coronary heart disease.

@en

Physician-prompting statin the ...... s with coronary heart disease.

@nl

P1476

Physician-prompting statin the ...... s with coronary heart disease.

@en

P2093

Amato CM

http://www.w3.org/2001/XMLSchema#string

Ashby CL

http://www.w3.org/2001/XMLSchema#string

Hilleman DE

http://www.w3.org/2001/XMLSchema#string

Mashni JE

http://www.w3.org/2001/XMLSchema#string

Monaghan MS

http://www.w3.org/2001/XMLSchema#string

Woolley K

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Using feedback letters to influence the use of antiulcer agents in a Medicaid program.

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service.

Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists.

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.

Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study.

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers.

P304

1415-1421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.21.17.1415.34422

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11714215

http://www.w3.org/2001/XMLSchema#string

P921

statin therapy